Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Olema Pharmaceuticals, Inc.
NASDAQ:OLMAHealthcare · Biotechnology
-4.50%$7.00
AH$7.12+1.71%vs close
Mkt Cap$612.48M
Float63.2M
O/S87.5M
Vol
$ Vol
RVOL
Inst Own-
SI24.8%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$162.45M
Total Assets$533.43M
Free Cash Flow-$146.72M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$1.19M
Total Equity$478.56M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in OLMA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$533.43M
Liabilities$54.87M
Accounts Receivable$4.06M
Accounts Payable$9.25M
Inventory$0
PP&E (Net)$1.15M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $11K | $9K | $8K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$11K | -$9K | -$8K |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $157.7M | $124.52M | $86.14M | $82.27M | $51.1M | $13.7M | $3.92M | $1.69M |
| Selling, General, and Administrative | $21M | $17.74M | $18.82M | $24.71M | $20.39M | $7.82M | $403K | $386K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $178.7M | $142.26M | $104.96M | $106.99M | $71.49M | $21.52M | $4.32M | $2.08M |
| Operating Income (EBIT) | -$178.7M | -$142.26M | -$104.96M | -$106.99M | -$71.49M | -$21.53M | -$4.32M | -$2.08M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $653K | - | $28K |
| Interest Income | $16.22M | $12.68M | $8.32M | $2.23M | $442K | $60K | $7K | $4K |
| Other Income (Expense) | $16.25M | $12.78M | $8.31M | $2.2M | $395K | -$593K | $7K | -$118K |
| Income Before Tax (EBT) | -$162.45M | -$129.47M | -$96.66M | -$104.79M | -$71.1M | -$22.12M | -$4.32M | -$2.2M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$162.45M | -$129.47M | -$96.66M | -$104.79M | -$71.1M | -$22.12M | -$4.32M | -$2.2M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| Diluted EPS | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| Weighted Average OS | 87.01M | 58.74M | 45.25M | 40.00M | 39.52M | 39.31M | 40.17M | 14.10M |
| EBITDA | -$161.96M | -$129.08M | -$96.28M | -$104.43M | -$70.93M | -$21.52M | -$4.31M | -$2.07M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $48.3M | $139.48M | $68.54M | $23.7M | $13.81M | $338.55M | $68K | $3.15M |
| Short-Term Investments | $457.14M | $294.61M | $193.27M | $180.72M | $273.44M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $505.44M | $434.09M | $261.81M | $204.42M | $287.25M | $338.55M | $68K | $3.15M |
| Accounts Receivable | $4.06M | $2.12M | $673K | $319K | $130K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.59M | $366K | $1.68M | $1.52M | $0 | $581K | $35K | $93K |
| Total Current Assets | $515.45M | $438.47M | $266.51M | $208.9M | $290.69M | $342.14M | $103K | $3.24M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $1.15M | $2.06M | $3.26M | $3.98M | $4.72M | $75K | $26K | $26K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $683K | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $16.83M | $9.76M | $7.17M | $2.77M | $540K | $510K | $3K | $3K |
| Total Long-Term Assets | $17.98M | $12.51M | $10.43M | $6.75M | $5.26M | $585K | $29K | $29K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $533.43M | $450.98M | $276.94M | $215.65M | $295.94M | $342.72M | $132K | $3.27M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $9.25M | $4.46M | $2.7M | $374K | $23K | $719K | $935K | $116K |
| Short-Term Debt | $1.12M | $1.17M | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $41K | $73K | $68K | $88K | $642K | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $32.02M | $30.31M | $5.46M | $4.6M | $3.96M | $436K | $443K | $85K |
| Total Current Liabilities | $51.8M | $41.76M | $21.62M | $16.55M | $9.02M | $4.58M | $1.38M | $201K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $69K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $3M | $0 | $0 | $0 | $0 | $0 | $9.35M | $9.35M |
| Total Long-Term Liabilities | $3.07M | $257K | $1.43M | $1.55M | $2.36M | $0 | $9.35M | $9.35M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $54.87M | $42.02M | $23.05M | $18.1M | $11.38M | $4.58M | $10.73M | $9.55M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $9.35M | $9.35M |
| Common Stock | $8K | $6K | $4K | $3K | $3K | $3K | $0 | $1K |
| Retained Earnings | -$597.56M | -$435.11M | -$305.63M | -$208.98M | -$104.19M | -$33.09M | -$10.76M | -$6.45M |
| Comprehensive Income & Other | $621K | $143K | $347K | -$1.81M | -$149K | $0 | -$80K | -$71K |
| Other Stockholders' Equity | $1.08B | $844.06M | $559.52M | $406.52M | $388.75M | $371.23M | $168K | $167K |
| Total Equity | $478.56M | $408.96M | $253.9M | $197.55M | $284.57M | $338.14M | -$10.59M | -$6.28M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $533.43M | $450.98M | $276.94M | $215.65M | $295.94M | $342.72M | $132K | $3.27M |
| Supplementary Data | ||||||||
| Total Debt | $1.19M | $1.43M | $2.42M | $2.56M | $3.29M | $0 | $0 | $0 |
| Net Debt | -$47.11M | -$138.05M | -$66.12M | -$21.14M | -$10.52M | -$338.55M | -$68K | -$3.15M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$162.45M | -$129.47M | -$96.66M | -$104.79M | -$71.1M | -$22.12M | -$4.32M | -$2.2M |
| Depreciation & Amortization | $490K | $393K | $377K | $357K | $163K | $11K | $9K | $8K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $17.59M | $22.58M | $17.26M | $0 | $0 | $3.11M | $0 | $1K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $4.6M | $2.51M | $2.32M | $351K | -$683K | -$220K | $1.17M | -$100K |
| Other Working Capital | -$1.82M | $6.65M | -$2.91M | $2.67M | $3.51M | -$1.28M | $58K | -$10K |
| Total Working Capital Change | $2.77M | $9.16M | -$589K | $3.02M | $2.83M | -$1.5M | $1.23M | -$110K |
| Other Non-Cash Items | -$5.12M | -$7.02M | -$4.12M | $19.34M | $17.41M | $641K | -$33 | $122K |
| Net Cash from Operating | -$146.72M | -$104.35M | -$83.73M | -$82.06M | -$50.69M | -$19.87M | -$3.08M | -$2.18M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | -$159K | $0 | -$363K | -$1.57M | -$56K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$500.72M | -$394.96M | -$255.63M | -$213.66M | -$486.97M | $0 | $0 | $0 |
| Sales of Investments | $344.96M | $301.59M | $250.76M | $305.5M | $213.1M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $14K | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$155.76M | -$93.53M | -$4.85M | $91.48M | -$275.44M | -$56K | $0 | $0 |
| Financing Activities | ||||||||
| Debt Repaid | -$3M | - | - | - | - | - | - | -$323K |
| Common Stock Issuance | $208.3M | $266.29M | $129.74M | $476K | $1.39M | $357.6M | $0 | $5.25M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$2.29M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $2.53M | $3.68M | $0 | $0 | $0 | $0 | $4.93M |
| Net Cash from Financing | $211.3M | $268.82M | $133.41M | $476K | $1.39M | $358.4M | $0 | $5.25M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$91.18M | $70.94M | $44.84M | $9.89M | -$324.74M | $338.48M | -$3.08M | $3.08M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$146.72M | -$104.35M | -$83.73M | -$82.06M | -$50.69M | -$19.87M | -$3.08M | -$2.18M |
| Capital Expenditure | $0 | -$159K | $0 | -$363K | -$1.57M | -$56K | $0 | $0 |
| Free Cash Flow | -$146.72M | -$104.51M | -$83.73M | -$82.43M | -$52.27M | -$19.92M | -$3.08M | -$2.18M |
| Cash at Beginning | $139.48M | $68.54M | $23.7M | $13.81M | $338.55M | $68K | $3.15M | $71K |
| Cash at End | $48.3M | $139.48M | $68.54M | $23.7M | $13.81M | $338.55M | $68K | $3.15M |